Allopurinol tablets recalled due to presence of foreign substance
Dr. Reddy's Laboratories is recalling Allopurinol 300mg tablets due to the presence of a foreign substance. Approximately 20,520 units were distributed in Illinois, Mississippi, and Ohio.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a prescription drug with confirmed contamination (foreign substance present). While no illnesses or injuries are reported in the source text, the contamination of a medication poses a risk of harm and warrants a High severity classification.
Plain-English summary
Dr. Reddy's Laboratories, Inc. is recalling Allopurinol (allopurinol) 300mg tablets, USP, in bottles of 100 tablets due to the presence of a foreign substance. The affected product carries NDC 55111-730-01 and lot code L2300594.
This is a Class II recall, indicating a potential health hazard. The recalled product was distributed to wholesalers and retailers in Illinois, Mississippi, and Ohio. Approximately 20,520 units are affected by this recall.
Patients taking this medication should consult their pharmacist or healthcare provider if they have questions or believe they have received affected product. Do not use this product if the lot code matches L2300594. Return affected product to the pharmacy or place of purchase.
The recalled product
- Product
- ALLOPURINOL (ALLOPURINOL)
- Brand
- ALLOPURINOL
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Category
- Drug — Prescription / Tablets
- Hazard
- foreign-substance-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- L2300594
UPCs (2)
- 0355111729013
- 0355111730019
Distribution
Distributed in 3 states:
- IL
- MS
- OH
Related recalls
Same brand · ALLOPURINOL
- ModerateAllopurinol tablets recalled due to improper storage conditions
FDA (Drugs) · 2024-01-03
- HighAllopurinol Tablets Recalled for Green Plastic Contamination
FDA (Drugs) · 2023-02-01
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27